These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26279176)

  • 21. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
    Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M; Namiki C; Thuy DH; Yoshida H; Kawasaki K; Hashikawa K; Fukuyama H; Kita T
    J Neurol Sci; 2004 Oct; 225(1-2):135-41. PubMed ID: 15465097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients.
    Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Clin Psychiatry; 2016 Jan; 77(1):e8-13. PubMed ID: 26845282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial.
    Montero-Odasso M; Muir-Hunter SW; Oteng-Amoako A; Gopaul K; Islam A; Borrie M; Wells J; Speechley M
    J Alzheimers Dis; 2015; 43(1):193-9. PubMed ID: 25079803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M
    Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of adjunctive donepezil for cognitive impairments in patients with schizophrenia].
    Mazza M; Pollice R; Gaspari V; Giosue P; Fragkou E; Roncone R; Casacchia M
    Clin Ter; 2005; 156(5):203-9. PubMed ID: 16382969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
    Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
    Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T; Wake R; Miyaoka T; Kawakami K; Nagahama M; Furuya M; Limoa E; Liaury K; Hashioka S; Murotani K; Horiguchi J
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):881-9. PubMed ID: 24436135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentration of donepezil to the cognitive response in Alzheimer disease.
    Yang YH; Chen CH; Chou MC; Li CH; Liu CK; Chen SH
    J Clin Psychopharmacol; 2013 Jun; 33(3):351-5. PubMed ID: 23609381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.